VidPrevtyn Beta, the COVID-19 vaccine developed by Sanofi, has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).
It becomes the seventh COVID-19 vaccine authorised by the UK’s independent medicines regulator, following expert advice from the government’s independent scientific advisory body, the Commission on Human Medicines.
VidPrevtyn Beta combines the spike protein from a COVID virus variant, Beta, with an ‘adjuvant’ – an additional ingredient designed to trigger a stronger immune response…
